US EditionPublished • loading... • Updated
PreEvnt brings non-invasive glucose alert device to clinical trials
Summary by Drug Delivery Business
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
PreEvnt brings non-invasive glucose alert device to clinical trials
The Isaac blood glucose alert device. [Image courtesy of PreEvnt]PreEvnt announced today that its Isaac non-invasive glucose monitoring system has entered clinical trials. Under the direction of Dr. Mangilal Agarwal, the device entered trials at Indiana University, Indianapolis. The study marks a step forward in validating Isaac’s potential as a tool for managing diabetes through breath-based measurements. The current phase of research includes …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
